Goldenwell Biotech, Inc. is a development stage company, which engages in the research and development and industrializes of healthcare products, biopharmaceuticals and bio-engineering drugs, and food and cosmetics products. The firm plans to develop, manufacture and market five products: Bovine Cardiac Vascular Active Peptide, Double Proline AG-3D Active Collagen Peptide, Cartilage Peptide-Type II Collagen Peptide, DNA Repair, and Sugar Master. The company was founded on August 20, 2019 and is headquartered in Hudson, OH.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company